Search
NP-50301
go.drugbank.com/drugs/DB05662ExperimentalIt is estimated that about 30% of postmenopausal women suffer symptoms of DES, which accounts for over 12 million women in the U.S. … NP-50301 is an ophthalmic therapeutic eye drop treating post-menopausal Dry Eye Syndrome (DES). It is being developed by Nascent Pharmaceuticals.
Biomed 101
go.drugbank.com/drugs/DB05851InvestigationalBiomed 101 is investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma. Biomed 101 is a solid.
Meclocycline
go.drugbank.com/drugs/DB13092InvestigationalMeclocycline is under investigation in clinical trial NCT00385515 (Efficacy of SNX-1012 in the Treatment of Oral Mucositis) [L797].
Categories: Anti-Acne Preparations for Topical UseAlamifovir
go.drugbank.com/drugs/DB06368ExperimentalAlamifovir is an antiviral agent specific for HBV.
Sitamaquine
go.drugbank.com/drugs/DB04909InvestigationalSitamaquine (WR-6026) is an orally active 8-aminoquinoline analog in development by the Walter Reed Army Institute, in collaboration with GlaxoSmithKline (formerly SmithKline Beecham), for the potential
Gossypol
go.drugbank.com/drugs/DB13044InvestigationalGossypol has been used in trials studying the treatment of Non-small Cell Lung Cancer.
Categories: Hormonal Contraceptives for Systemic UseCeftezole
go.drugbank.com/drugs/DB13821InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseCefbuperazone
go.drugbank.com/drugs/DB13638ExperimentalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseCefatrizine
go.drugbank.com/drugs/DB13266InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use